First reported by y94.com
US FDA approves Celcuity’s breast cancer drug
Celcuity gets FDA nod for first-in-class breast cancer drug
Celcuity gets FDA nod for first-in-class breast cancer drug Phil.Taylor Wed, 15/07/2026 - 09:10
Read the full articleYou might also wanna read
With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
The FDA has approved a new small molecule inhibitor from Celcuity with blockbuster potential that could become a new standard-of-care for pa
Fierce Biotech·2d ago
US FDA approves Celcuity’s breast cancer drug
By Kunal Das and Christy Santhosh July 14 (Reuters) - The U.S. FDA has approved Celcuity's drug for an advanced form of breast cancer, the r
KRWK·2d ago
US FDA approves Celcuity’s breast cancer drug
By Kunal Das and Christy Santhosh July 14 (Reuters) - The U.S. FDA has approved Celcuity's drug for an advanced form of breast cancer, the r
y94.com·2d ago
Celcuity (CELC) Receives FDA Approval for Breakthrough Breast Cancer Treatment
Related Stocks: CELC
GuruFocus·2d ago
Celcuity (CELC) Secures FDA Approval for Revtorpyk in Breast Cancer Treatment
Related Stocks: CELC
GuruFocus·2d ago
Celcuity wins breast cancer nod, securing ‘differentiated foothold’ in market
Celcuity’s first approved drug, Revtorpyk, is indicated for the second-line treatment of advanced HER2- breast cancer patients without PIK3C
BioSpace·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.